Skip to content

Drug interactions

Deutetrabenazine + Pimavanserin

Severity: Moderate

Deutetrabenazine and Pimavanserin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs can cause sedation and parkinsonism, and deutetrabenazine may cause modest QT prolongation. Concurrent use may increase the risk of extrapyramidal symptoms, sedation, and rarely neuroleptic malignant syndrome.

What this interaction means in plain words

Deutetrabenazine and Pimavanserin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Deutetrabenazine belongs to Central Nervous System; Pimavanserin belongs to Central Nervous System.

Evidence level: Low

Why it happens

Additive antidopaminergic effects via VMAT2 inhibition and antipsychotic activity, with additive CNS depression and QT effects.

What to do

Monitor for parkinsonism, akathisia, sedation, and signs of neuroleptic malignant syndrome. Consider an ECG if other QT-prolonging drugs or risk factors are present.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Deutetrabenazine and Pimavanserin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Deutetrabenazine with Pimavanserin?

MediHelp rates the interaction as moderate. Deutetrabenazine and Pimavanserin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs can cause sedation and parkinsonism, and deutetrabenazine may cause modest QT prolongation. Concurrent use may increase the risk of extrapyramidal symptoms, sedation, and rarely neuroleptic malignant syndrome.

How serious is the interaction between Deutetrabenazine and Pimavanserin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for parkinsonism, akathisia, sedation, and signs of neuroleptic malignant syndrome. Consider an ECG if other QT-prolonging drugs or risk factors are present.

What other medicines interact with Pimavanserin?

MediHelp also lists interactions of Pimavanserin with, for example, Lefamulin, Pimozide, Vandetanib. The full list is on the Pimavanserin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in